Oral and subcutaneous administration of the glycosaminoglycan C3 attenuates Aβ(25–35)-induced abnormal tau protein immunoreactivity in rat brain

Autor: Dudas, B, Cornelli, U, Lee, J.M, Hejna, M.J, Walzer, M, Lorens, S.A, Mervis, R.F, Fareed, J, Hanin, I
Zdroj: In Neurobiology of Aging 2002 23(1):97-104
Databáze: ScienceDirect